Cargando…
HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC
β-catenin nuclear accumulation is frequently identified in human non-small cell lung cancer (NSCLC). The HMG-box transcription factor 1 (HBP1) is a known repressor of β-catenin transactivation. However, the role of HBP1 in relation to β-catenin nuclear accumulation has not been addressed in human ca...
Autores principales: | Tseng, Ruo-Chia, Huang, Way-Ren, Lin, Su-Feng, Wu, Pei-Chen, Hsu, Han-Shui, Wang, Yi-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196651/ https://www.ncbi.nlm.nih.gov/pubmed/24895061 http://dx.doi.org/10.1111/jcmm.12318 |
Ejemplares similares
-
Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021) -
miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1
por: Li, Kui, et al.
Publicado: (2020) -
GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness
por: Jia, Chunzeng, et al.
Publicado: (2020) -
Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
por: Wang, Jiyin, et al.
Publicado: (2022) -
MiR‐155 promotes colitis‐associated intestinal fibrosis by targeting HBP1/Wnt/β‐catenin signalling pathway
por: Li, Nianshuang, et al.
Publicado: (2021)